Cohort Study of Intrauterine Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorWenwen Wang
About this trial
"This study employs a prospective cohort design by establishing a uterine cavity diseases research platform. The investigators will collect participants' current medical history, menstrual and obstetric history, past medical history, physical and gynecological examinations, imaging studies, laboratory tests, and pathological examinations. After the hysteroscopic surgery, the investigators will conduct a one-year follow-up on the disease progression of the participants. Through this comprehensive approach, the investigators aim to deeply investigate the pathogenesis, risk factors, and optimized treatment strategies for uterine cavity diseases."
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 18-80 years;
Patients requiring hysteroscopy or diagnostic curettage for intrauterine pathologies (e.g., endometrial hyperplasia, endometrial polyps, submucosal uterine fibroids, adenomyosis, or endometrial malignancies);
Willing and able to comply with follow-up requirements;
Signed informed consent obtained.
Disqualifiers
Concurrent participation in other drug clinical trials;
Contraindications to or inability to tolerate hysteroscopy/curettage procedures;
Unwilling or unable to provide informed consent;
Unwilling or unable to adhere to study protocols.
Trial population
Study Population will be enrolled by a multicenter study led by Tongji Hospital , in collaboration with over 30 tertiary hospitals. Patients requiring hysteroscopic or curettage procedures for intrauterine lesions such as endometrial hyperplasia, polyps, and malignancies will be recruited.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No intervention (observational study)
Other interventionNo intervention (observational study)
Treatment groups
2,000 Participants
are divided into 1 treatment groupGroup A: Intrauterine Diseases Cohort1 intervention
Trial outcomes
Primary outcomes
1
The recurrence of endometrial polyps or endometrial hyperplasia.
To evaluate the presence of disease progression and recurrence through imaging results.
Time frame
Follow up every three months for one year after hysteroscopic surgerySponsors and contacts
Click on the lead sponsor to view all of their trials.
Wenwen Wang
Lead sponsor
Tongji Hospital
Sponsor institution
Source ClinicalTrials.gov